Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | MGLL | Q99685 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.40 |
| ▸ | FBP1 | P09467 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | KIF11 | P52732 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23904120 | 1.00 | TP53 (0.53) | TP53MEN1POLBKMT2ACA1 | |
| SCHEMBL18185662 | 0.86 | FBP1 (0.48) | ALDH1A1FBP1AKR1C3CYP3A4 | |
| SCHEMBL3726260 | 0.86 | FBP1 (0.48) | ALDH1A1FBP1AKR1C3CYP3A4 | |
| SCHEMBL21873481 | 0.86 | FBP1 (0.48) | ALDH1A1FBP1AKR1C3CYP3A4 | |
| SCHEMBL657316 | 0.82 | TP53 (0.57) | TP53MEN1POLBKMT2ACA1 | |
| SCHEMBL26604330 | 0.82 | TP53 (0.57) | TP53MEN1POLBKMT2ACA1 | |
| SCHEMBL18970461 | 0.77 | TP53 (0.61) | TP53MEN1POLBKMT2ACA1 | |
| SCHEMBL7074200 | 0.75 | TP53 (0.66) | TP53MEN1POLBKMT2ACA1 | |
| SCHEMBL7074203 | 0.75 | TP53 (0.66) | TP53MEN1POLBKMT2ACA1 | |
| SCHEMBL28365357 | 0.74 | TP53 (0.48) | TP53MEN1POLBKMT2ACA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3892611-B1 | METHOD FOR PRODUCING FLUOROVINYL AMIDE COMPOUND | DAIKIN IND LTD (JP) | 2026-01-28 | — | — | EP | disclosed |
| US-20250214936-A1 | METHOD FOR PRODUCING FLUOROVINYL AMIDE COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2025-07-03 | — | — | US | disclosed |
| US-12281075-B2 | Method for producing fluorovinyl amide compound | DAIKIN INDUSTRIES, LTD. (JP) | 2025-04-22 | — | — | US | disclosed |
| US-20220055990-A1 | METHOD FOR PRODUCING FLUOROVINYL AMIDE COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2022-02-24 | — | — | US | disclosed |
| EP-3892611-A1 | METHOD FOR PRODUCING FLUOROVINYL AMIDE COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2021-10-13 | — | — | EP | disclosed |
| CN-113166039-A | Process for producing fluorovinylamide compound | 大金工业株式会社 | 2021-07-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12281075-B2 | Method for producing fluorovinyl amide compound | RB1, KRAS, NRAS | TP53 38/4885MEN1 487/4885POLB 2150/4885 |
| US-20250214936-A1 | METHOD FOR PRODUCING FLUOROVINYL AMIDE COMPOUND | RB1, KRAS, NRAS | TP53 38/4885MEN1 487/4885POLB 2150/4885 |
| US-20220055990-A1 | METHOD FOR PRODUCING FLUOROVINYL AMIDE COMPOUND | RB1, KRAS, NRAS | TP53 38/4885MEN1 487/4885POLB 2150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.